United States Pharmaceuticals

cbdMD Inc (YCBD)

Track

The most recent insider trading activity for cbdMD Inc. occurred on December 17, 2025. During this period, insider Clark R. Crosnoe executed multiple sell transactions and filed a proposed sale of shares. No further insider trading activity has been reported in the last three months.
Ticker: YCBD Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for cbdMD Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 17 Dec 2025
Value US$2,747,943.91 | Price 474.33 | Shares 30,296 (+15.5%)
Sale 17 Dec 2025
Value US$3,774,673.59 | Price 41.46 | Shares 3,063 (-35.8%)
Sale 17 Dec 2025
Value US$1,068,246.96 | Price 2.31 | Shares 461,725 (-56.1%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-19 2025-12-17 S Sale
3.9
Crosnoe Clark R.
Large shareholder
30,296 +15.5%
474.33
US$2,747,944 		30,296 +15.5% 474.33 US$2,747,944
2025-12-19 2025-12-17 S Sale
3.9
Crosnoe Clark R.
Large shareholder
3,063 -35.8%
41.46
US$3,774,674 		3,063 -35.8% 41.46 US$3,774,674
2025-12-19 2025-12-17 S Sale
3.9
Crosnoe Clark R.
Large shareholder
19,453 -47.0%
374.77
US$816,405 		19,453 -47.0% 374.77 US$816,405
2025-12-17 2025-12-17 PrS Proposed sale
3.9
Clark R. Crosnoe, CRC Investment Fund LP, NM 2018 Trust dated April 4, 2018, AMC Legacy Trust dated December 21, 2012

Stockholder

Large shareholder
986,851
2.25
US$2,220,415 		986,851 2.25 US$2,220,415
2021-07-26 2021-07-22 B Purchase
Wiesehan John J III

Chief Revenue Officer

Officer
161,550
0.00
US$0 		161,550 0.00 US$0
2021-03-12 2021-03-11 S Sale
3.4
Sumichrast Martin A.

Chairman & CO-CEO

Executive Director
65,493 -4.4%
3.93
US$257,564 		65,493 -4.4% 3.93 US$257,564
2021-03-12 2021-03-10 S Sale
3.4
Sumichrast Martin A.

Chairman & CO-CEO

Executive Director
59,507 -3.8%
4.04
US$240,117 		59,507 -3.8% 4.04 US$240,117
2021-03-03 2021-03-02 S Sale
3.2
Raines William F III
Non-Executive Director
20,000 -93.7%
4.04
US$80,748 		20,000 -93.7% 4.04 US$80,748
2021-02-23 2021-02-22 S Sale
3.7
Coffman Raymond Scott

CO-CEO, President, Director

Executive Director Large shareholder
122,000 -100.0%
4.25
US$518,805 		122,000 -100.0% 4.25 US$518,805
2021-02-23 2021-02-19 S Sale
3.7
Coffman Raymond Scott

CO-CEO, President, Director

Executive Director Large shareholder
3,000 -2.4%
4.28
US$12,846 		3,000 -2.4% 4.28 US$12,846
2021-02-19 2021-02-19 S Sale
3.4
Sumichrast Martin A.

Chairman & CO-CEO

Executive Director
240,035 -100.0%
4.42
US$1,059,971 		240,035 -100.0% 4.42 US$1,059,971
2021-02-19 2021-02-18 S Sale
3.4
Sumichrast Martin A.

Chairman & CO-CEO

Executive Director
113,104 -32.0%
4.43
US$500,768 		113,104 -32.0% 4.43 US$500,768
2021-02-19 2021-02-17 S Sale
3.4
Sumichrast Martin A.

Chairman & CO-CEO

Executive Director
42,461 -10.7%
4.54
US$192,764 		42,461 -10.7% 4.54 US$192,764
2020-08-18 2020-08-14 S Sale
3.3
Sellers Bakari T.
Non-Executive Director
10,000 -79.8%
3.43
US$34,300 		10,000 -79.8% 3.43 US$34,300
2020-03-10 2020-03-09 B Purchase
2.8
Ghiloni Peter J.
25,000 +9.1%
0.75
US$18,720 		25,000 +9.1% 0.75 US$18,720
2020-02-25 2020-01-27 B Purchase
2.1
Elliott Mark S

CFO & COO
5,000 +10.7%
1.06
US$5,300 		5,000 +10.7% 1.06 US$5,300
2020-01-16 2020-01-14 B Purchase
3.7
Coffman Raymond Scott

CO-CEO
125,000 +1.0%
1.00
US$125,000 		125,000 +1.0% 1.00 US$125,000
2020-01-16 2020-01-14 B Purchase
1.6
Morris Gregory C
15,000 +592.7%
1.00
US$15,000 		15,000 +592.7% 1.00 US$15,000
2020-01-16 2020-01-14 B Purchase
3.3
Sellers Bakari T.
10,000 +395.1%
1.00
US$10,000 		10,000 +395.1% 1.00 US$10,000
2020-01-16 2020-01-14 B Purchase
1.6
Stephen Scott G.
20,000 +95.0%
1.00
US$20,000 		20,000 +95.0% 1.00 US$20,000
2020-01-16 2020-01-14 B Purchase
2.8
Ghiloni Peter J.
125,000 +83.3%
1.00
US$125,000 		125,000 +83.3% 1.00 US$125,000
2020-01-16 2020-01-14 B Purchase
3.4
Sumichrast Martin A.

CO-CEO
125,000 +46.2%
1.00
US$125,000 		125,000 +46.2% 1.00 US$125,000
2020-01-16 2020-01-14 B Purchase
2.1
Elliott Mark S

CFO & COO
15,000 +47.3%
1.00
US$15,000 		15,000 +47.3% 1.00 US$15,000
2020-01-16 2020-01-14 B Purchase
3.2
Raines William F III
20,000 +21.3%
1.00
US$20,000 		20,000 +21.3% 1.00 US$20,000
2019-04-17 2019-04-16 S Sale
0.7
Sterling Erik
Large shareholder
583,000 -100.0%
4.00
US$2,332,000 		583,000 -100.0% 4.00 US$2,332,000
2019-04-17 2019-04-16 S Sale
0.7
Sterling Erik
Large shareholder
283,000 -100.0%
4.00
US$1,132,000 		283,000 -100.0% 4.00 US$1,132,000
2019-04-17 2019-04-16 S Sale
0.7
Sterling Erik
Large shareholder
166,667 -100.0%
4.00
US$666,668 		166,667 -100.0% 4.00 US$666,668
2019-04-17 2019-04-16 S Sale
0.7
Sterling Erik
Large shareholder
25,000 -100.0%
4.00
US$100,000 		25,000 -100.0% 4.00 US$100,000
2019-03-08 2019-03-07 S Sale
3.4
Sumichrast Martin A.

Chairman of the Board and CEO
325,834 -54.6%
4.00
US$1,303,336 		325,834 -54.6% 4.00 US$1,303,336
2019-02-22 2019-02-20 S Sale
3.4
Sumichrast Martin A.

Chairman of the Board and CEO
150,000 -20.1%
4.00
US$600,000 		150,000 -20.1% 4.00 US$600,000
Explore more

More insider trading research around cbdMD Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America